Seer, Inc. faces a challenging fundamental outlook characterized by a 33.6% year-over-year revenue contraction in 2026Q1 and persistent operating losses that continue to erode the company's equity base.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 11, 2026 | -$0.31-14.8% vs -$0.27 | $3M-12.6% vs $4M |
Q2 2026 May 13, 2026 | -$0.30-1.7% vs -$0.29 | $3M-22.4% vs $4M |
Q1 2026 Feb 26, 2026 | -$0.29+9.4% vs -$0.32 | $4M-8.7% vs $5M |
Q4 2025 Nov 6, 2025 | -$0.32+0.0% vs -$0.32 | $4M-10.4% vs $5M |
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer's Board of Directors (the “Special Committee”) has concluded its review process and decided to reject the recent acquisition proposals made to Seer.
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced updated follow-up analyses from a Phase 2 trial evaluating petosemtamab, an investigational IgG1-bispecif
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated inve
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the third quarter 2026 on Tuesday, November 10, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Benchmark SEER against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Seer, Inc. (SEER)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.63 | $89.62M | -1.32 | 15.57% | -490.71% | -27.23% | — | |
| $2.90 | $136.61M | -1.11 | 2.38% | -80.29% | -43.59% | — | |
| $78.56 | $4.06B | 33.58 | 13.79% | 25.86% | 34.08% | — | |
| $2.23 | $283.78M | -4.84 | — | -13816.75% | -42.68% | — | |
| $213.13 | $32.25B | 36.67 | -0.78% | 19.72% | 31.45% | — | |
| $2.26 | $701.96M | -5.36 | 3.89% | -81.31% | -2618.51% | — |
Seer, Inc. (SEER) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Seer, Inc. (SEER) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 11, 2026·SEC
Jul 31, 2026·SEC
Jul 31, 2026·SEC
Get notified when SEER posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Seer, Inc. (SEER) stock FAQ — growth, dividends, profitability & financials explained
Seer, Inc. (SEER) reported $13.8M in revenue over the trailing twelve months. Revenue was $16.1M in fiscal year 2025.
Seer, Inc. (SEER) revenue fell by 13.3% over the trailing twelve months, compared with the twelve months before.
No. Seer, Inc. (SEER) reported a net loss of $68.0M over the trailing twelve months.
Seer, Inc. (SEER) had a return on equity (ROE) of -27.2% over the trailing twelve months. A negative ROE means the company lost money over the period.
Seer, Inc. (SEER) had negative free cash flow of $44.2M over the trailing twelve months.
